Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
intellectual property
Biotech
AbbVie alleges Genmab 'willfully blind' to trade secret theft
Genmab sees things differently, saying it “categorically refutes allegations and will vigorously defend the company.”
Nick Paul Taylor
Mar 24, 2025 5:51am
George Church spinout restructures, considers strategic options
Mar 13, 2025 2:00pm
Agilent loses 2 CRISPR patents after Synthego wins IP cases
May 18, 2023 9:05am
Insulet buys Bigfoot’s automated insulin delivery patents
Feb 13, 2023 11:54am
Regor notches minor victory in trade secrets feud with Pfizer
Feb 8, 2023 9:30am
Boston Scientific fined $42M in stent patent lawsuit
Feb 3, 2023 11:17am
